News

Dec 14, 2017
A long-term analysis of yttrium 90 (Y90) radioembolization for patients with advanced stage hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) assessed safety and efficacy. | Read More
Dec 12, 2017
Researchers conducted a retrospective review to determine which factors may predict local tumor progression (LTP)-free survival after radiofrequency ablation and microwave ablation of colorectal liver metastases. | Read More
Dec 05, 2017
Dynamic CT studies are a typical part of the preoperative evaluation of the hypervascularity of hepatocellular carcinoma (HCC), but certain patients may benefit from the addition of computed tomography during hepatic arteriography (CTHA). | Read More
Nov 30, 2017
The study compared radiation segmentectomy versus transarterial chemoembolizaton for patients with early-stage HCC. | Read More
Nov 28, 2017
In this study, the authors assessed whether patients who have recurrent hepatocellular carcinoma following resection can benefit from radioembolization. | Read More
Nov 21, 2017
In a study published in JVIR, researchers compared patient satisfaction, adverse events, and other factors associated with transradial and transfemoral access. | Read More
Nov 13, 2017
The study examined whether local control of adrenal gland metastases that measure < 5 cm can be accomplished through the use of image-guided ablation. | Read More
Nov 09, 2017
Researchers compared survival outcomes in patients with localized T1a clear cell renal cell carcinoma who were treated with local ablation compared with deferred surgical therapy. | Read More
Nov 07, 2017
Researchers evaluated the safety and cytoreductive effects of drug-eluting embolic agent (DEE) transarterial chemoembolization compared with transarterial embolization for treating renal cell carcinoma. | Read More
Oct 30, 2017
Researchers compared liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization (TACE) in patients with cirrhosis and large, solitary HCC tumors. | Read More